Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2026-05-07 @ 7:04 PM
Study NCT ID:
NCT04447469
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2020-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Sponsor:
Kiniksa Pharmaceuticals International, plc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KPL-301-C203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |